The serum glycoprotein fetuin-A promotes lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms

Cancer Research

Volumn 65, Issue 2, 2005, Pages 499-506

  Kundranda, Madappa N ^a   Henderson, Melodie ^a   Carter, Kathy J ^a   Gorden, Lee ^a   Binhazim, Awadh ^b   Ray, Sanhita ^a   Baptiste, Trevor ^a   Shokrani, Masih ^a   Leite Browning, Maria L ^a   Jahnen Dechent, Willi ^c   Matrisian, Lynn M ^a   Ochieng, Josiah ^a,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN; FETUIN A; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ADHESION; GENE LOCUS; LEWIS CARCINOMA; LUNG METASTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR GROWTH; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-FETOPROTEINS; ANIMALS; CALCIUM; CALCIUM SIGNALING; CARCINOMA, LEWIS LUNG; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHROMONES; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MORPHOLINES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 19944431758     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Olivier E, Soury E, Ruminy P, et al. Fetuin-B, a second member of the fetuin family in mammals. Biochem J 2000;350 Pt 2:589-97.
2. Brown WM, Saunders NR, Mollgard K, Dziegielewska KM. Fetuin: an old friend revisited. BioEssays 1992;14:749-55.
3. Dziegielewska KM, Brown WM, Casey SJ, et al. The complete cDNA and amino acid sequence of bovine fetuin. Its homology with α 2HS glycoprotein and relation to other members of the cystatin superfamily. J Biol Chem 1990;265:4354-7.
4. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human α 2 HS glycoprotein during the inflammatory process: evidence that a 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979;64:1118-29.
5. Jahnen-Dechent W, Schinke T, Trindl A, et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997;272:31496-503.
6. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophage-deactivating molecules. Proc Natl Acad Sci U S A 1998;95:14429-34.
7. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/α2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J Biol Chem 1996;271:12755-61.
8. Szweras M, Liu D, Partridge EA, et al. α 2-HS glycoprotein/fetuin, a transforming growth factor-β/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002;277:19991-7.
9. Nie Z. Fetuin: its enigmatic property of growth promotion. Am J Physiol 1992;263:C551-62.
10. Schafer C, Heiss A, Schwarz A, et al. The serum protein α 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
11. Warfield PR, Makker PN, Raz A, Ochieng J. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis 1997;17:101-12.
12. Yu CL, Tsai MH. Fetal fetuin selectively induces apoptosis in cancer cell lines and shows anti-cancer activity in tumor animal models. Cancer Lett 2001;166:173-84.
13. Raz A, Lotan R. Lectin-like activities associated with human and murine neoplastic cells. Cancer Res 1981;41:3642-7.
14. Ahmed SA, Gogal RM Jr, Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods 1994;170:211-24.
15. Johnson DE, Ochieng J, Evans SL. Phenylacetic acid halides inhibit estrogen receptor (ER)-positive MCF-7 cells, but not ER-negative human breast cancer cells or normal breast epithelial cells. Anticancer Drugs 1996;7:288-92.
16. Mitsiades CS, Mitsiades N, Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 2004;4:235-56.
17. Kundranda MN, Ray S, Saria M, et al. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochim Biophys Acta 2004;1693:111-23.
18. Brodt P. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res 1986;46:2442-8.
19. Sanchez-Mateos P, Cabanas C, Sanchez-Madrid F. Regulation of integrin function. Semin Cancer Biol 1996;7:99-109.
20. Makker PNT, EW, Hogan C, Ochieng J, Raz A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 1995;7:1079-87.
21. Ishikawa Y, Wu LN, Valhmu WB, Wuthier RE. Fetuin and α-2HS glycoprotein induce alkaline phosphatase in epiphyseal growth plate chondrocytes. J Cell Physiol 1991;149:222-34.
22. Hui MZ, Tenenbaum HC, McCulloch CA. Collagen phagocytosis and apoptosis are induced by high level alkaline phosphatase expression in rat fibroblasts. J Cell Physiol 1997;172:323-33.
23. Fidler IJ. The biology of cancer metastasis or, "you cannot fix it if you do not know how it works". BioEssays 1991;13:551-4.
24. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W. The serum protein α2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 1996;271:20789-96.
25. Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J. Interactions of α2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. Int J Oncol 2002;21:965-71.
26. Kojima K, Yamamoto K, Irimura T, Osawa T, Ogawa H, Matsumoto I. Characterization of carbohydrate-binding protein p33/41: relation with Annexin IV, molecular basis of the doublet forms (p33 and p41), and modulation of the carbohydrate binding activity by phospholipids. J Biol Chem 1996;271:7679-85.
27. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
28. Frey BM, Reber BF, Vishwanath BS, Escher G, Frey FJ. Annexin I modulates cell functions by controlling intracellular calcium release. FASEB J 1999;13:2235-45.
29. Fleet A, Ashworth R, Kubista H, et al. Inhibition of EGF-dependent calcium influx by Annexin VI is splice form-specific. Biochem Biophys Res Commun 1999;260:540-6.
30. Rothhut B. Participation of annexins in protein phosphorylation. Cell Mol Life Sci 1997;53:522-6.
31. Chiang Y, Rizzino A, Sibenaller ZA, Wold MS, Vishwanatha JK. Specific down-regulation of Annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 1999;199:139-47.
32. Leite-Browning ML, McCawley LJ, Jahnen-Dechent W, King LE, Jr, Matrisian LM, Ochieng J. α 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. Int J Oncol 2004;25:319-24.
33. Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C, Sethi T. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 1998;58:5239-47.
34. Kuppumbatti YS, Rexer B, Nakajo S, Nakaya K, Mira-y-Lopez R. CRBP suppresses breast cancer cell survival and anchorage-independent growth. Oncogene 2001;20:7413-19.
35. Khaleghpour K, Li Y, Banville D, Yu Z, Shen SH. Involvement of the Pl 3-kinase signaling pathway in progression of colon adenocarcinoma. Carcinogenesis 2004;25:241-8.
36. Raz A, Zhu DG, Hogan V, et al. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 1990;46:871-7.
37. Baskies AM, Chretien PB, Weiss JF, et al. Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer 1980;45:3050-60.